Introduction: Smith-Lemli-Opitz syndrome (SLOS), a genetic developmental disorder characterized by various congenital anomalies, arises from a loss of normal DHCR7 enzymatic action in cholesterol biosynthesis. This syndrome is typically marked by various congenital anomalies, including microcephaly with cognitive impairments, distinctive facial features, and syndactyly of the toes (2-3 fusion). Case Presentation: A 73-year-old woman, followed up on by the neurology clinic for the last 3 years for amnesia and movement disorders, was referred to our clinic for genetic etiology investigation. Although there were no significant dysmorphic findings on her physical examination, observations included partial syndactyly between the second and third toes of both feet, a wide forehead, and a triangular face. We used the whole-exome sequencing (WES) analysis to evaluate the patient because of their various phenotype, which included dysmorphic features, movement problems, recurrent hip dislocation, mild intellectual impairment. WES analysis revealed a homozygous missense c.1295A>G (p.Tyr432Cys) variation in DHCR7 gene. Discussion: A total of 9 patients with p.Tyr432Cys variant have been reported in the literature so far. The present case is the first patient with biallelic c.1295A>G (p.Tyr432Cys) variation in DHCR7 gene in the current literature. Diagnosing the disorder can be challenging, particularly in its milder manifestations, given the extensive range of clinical presentations. The present case is the oldest patient with SLOS reported in the relevant literature. Mild dysmorphic features, mild intellectual disability, and recurrent hip dislocation, along with the typical finding of syndactyly between the second and third toes in the foot, may indicate mild forms of SLOS.

1.
Jira
PE
,
Waterham
HR
,
Wanders
RJ
,
Smeitink
JA
,
Sengers
RC
,
Wevers
RA
.
Smith-Lemli-Opitz syndrome and the DHCR7 gene
.
Ann Hum Genet
.
2003
;
67
(
Pt 3
):
269
80
. .
2.
Park
JE
,
Lee
T
,
Ha
K
,
Ki
CS
.
Carrier frequency and incidence estimation of Smith-Lemli-Opitz syndrome in East Asian populations by Genome Aggregation Database (gnomAD) based analysis
.
Orphanet J Rare Dis
.
2021
;
16
(
1
):
166
. .
3.
Witsch-Baumgartner
M
,
Schwentner
I
,
Gruber
M
,
Benlian
P
,
Bertranpetit
J
,
Bieth
E
, et al
.
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations
.
J Med Genet
.
2008
;
45
(
4
):
200
9
. .
4.
Tucci
A
,
Ronzoni
L
,
Arduino
C
,
Salmin
P
,
Esposito
S
,
Milani
D
.
The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome
.
BMC Med Genet
.
2016
;
17
:
22
. .
5.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
, et al
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
. .
6.
Smıth
DW
,
Lemlı
L
,
Opıtz
JM
.
A newly recognized syndrome of multiple congenital anomalies
.
J Pediatr
.
1964
;
64
:
210
7
. .
7.
Curry
CJ
,
Carey
JC
,
Holland
JS
,
Chopra
D
,
Fineman
R
,
Golabi
M
, et al
.
Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality
.
Am J Med Genet
.
1987
;
26
(
1
):
45
57
. .
8.
Fitzky
BU
,
Witsch-Baumgartner
M
,
Erdel
M
,
Lee
JN
,
Paik
YK
,
Glossmann
H
, et al
.
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome
.
Proc Natl Acad Sci U S A
.
1998
;
95
(
14
):
8181
6
. .
9.
Wassif
CA
,
Maslen
C
,
Kachilele-Linjewile
S
,
Lin
D
,
Linck
LM
,
Connor
WE
, et al
.
Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome
.
Am J Hum Genet
.
1998
;
63
(
1
):
55
62
. .
10.
Waterham
HR
,
Wijburg
FA
,
Hennekam
RC
,
Vreken
P
,
Poll-The
BT
,
Dorland
L
, et al
.
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene
.
Am J Hum Genet
.
1998
;
63
(
2
):
329
38
. .
11.
Witsch-Baumgartner
M
,
Fitzky
BU
,
Ogorelkova
M
,
Kraft
HG
,
Moebius
FF
,
Glossmann
H
, et al
.
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome
.
Am J Hum Genet
.
2000
;
66
(
2
):
402
12
. .
12.
Prabhu
AV
,
Luu
W
,
Li
D
,
Sharpe
LJ
,
Brown
AJ
.
DHCR7: a vital enzyme switch between cholesterol and vitamin D production
.
Prog Lipid Res
.
2016
;
64
:
138
51
. .
13.
Kelley
RI
,
Hennekam
RC
.
The Smith-Lemli-Opitz syndrome
.
J Med Genet
.
2000
;
37
(
5
):
321
35
. .
14.
Witsch-Baumgartner
M
,
Clayton
P
,
Clusellas
N
,
Haas
D
,
Kelley
RI
,
Krajewska-Walasek
M
, et al
.
Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy
.
Hum Mutat
.
2005
;
25
(
4
):
412
. .
15.
Balogh
I
,
Koczok
K
,
Szabó
GP
,
Török
O
,
Hadzsiev
K
,
Csábi
G
, et al
.
Mutational spectrum of smith-lemli-opitz syndrome patients in Hungary
.
Mol Syndromol
.
2012
;
3
(
5
):
215
22
. .
16.
Kalb
S
,
Caglayan
AO
,
Degerliyurt
A
,
Schmid
S
,
Ceylaner
S
,
Hatipoglu
N
, et al
.
High frequency of p.Thr93Met in Smith-Lemli-Opitz syndrome patients in Turkey
.
Clin Genet
.
2012
;
81
(
6
):
598
601
. .
17.
Haas
D
,
Garbade
SF
,
Vohwinkel
C
,
Muschol
N
,
Trefz
FK
,
Penzien
JM
, et al
.
Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS)
.
J Inherit Metab Dis
.
2007
;
30
(
3
):
375
87
. .
18.
Kolejáková
K
,
Petrovic
R
,
Futas
J
,
Turcáni
P
,
Durovcíková
D
,
Chandoga
J
.
Spectrum of DHCR7 mutations in Slovak patients with Smith-Lemli-Opitz syndrome and detection of common mutations by PCR-based assays
.
Gen Physiol Biophys
.
2009
;
28
(
1
):
8
15
. .
19.
Ciara
E
,
Popowska
E
,
Piekutowska-Abramczuk
D
,
Jurkiewicz
D
,
Borucka-Mankiewicz
M
,
Kowalski
P
, et al
.
SLOS carrier frequency in Poland as determined by screening for Trp151X and Val326Leu DHCR7 mutations
.
Eur J Med Genet
.
2006
;
49
(
6
):
499
504
. .
20.
Değerliyurt
A
,
Kılıç
G
,
Aycan
Z
,
Ceylaner
S
.
A smith lemli opitz syndrome patient diagnosed with mild symptoms
.
Turkiye Klinikleri J Pediatr
.
2010
;
19
(
2
):
191
4
.
21.
Nissinen
MJ
,
Gylling
H
,
Kaski
M
,
Tammisto
P
,
Mieskonen
S
,
Ignatius
J
, et al
.
Smith-Lemli-Opitz syndrome and other sterol disorders among Finns with developmental disabilities
.
J Lab Clin Med
.
2000
;
136
(
6
):
457
67
. .
22.
Lee
RW
,
Conley
SK
,
Gropman
A
,
Porter
FD
,
Baker
EH
.
Brain magnetic resonance imaging findings in Smith-Lemli-Opitz syndrome
.
Am J Med Genet A
.
2013
;
161A
(
10
):
2407
19
. .
23.
Lowry
RB
,
Yong
SL
.
Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome
.
Am J Med Genet
.
1980
;
5
(
2
):
137
43
. .
24.
Ellingson
MS
,
Wick
MJ
,
White
WM
,
Raymond
KM
,
Saenger
AK
,
Pichurin
PN
, et al
.
Pregnancy in an individual with mild Smith-Lemli-Opitz syndrome
.
Clin Genet
.
2014
;
85
(
5
):
495
7
. .
You do not currently have access to this content.